Y-mAbs Therapeutics, Inc.
YMAB
$4.67
-$0.06-1.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -29.67M | -23.86M | -24.61M | -21.67M | -21.43M |
| Total Depreciation and Amortization | 535.00K | 594.00K | 641.00K | 712.00K | 735.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.07M | 13.26M | 13.06M | 12.68M | 13.19M |
| Change in Net Operating Assets | -3.65M | -11.87M | -1.64M | -9.32M | -19.73M |
| Cash from Operations | -15.71M | -21.88M | -12.55M | -17.59M | -27.23M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.31M | 3.43M | 2.45M | 688.00K | 100.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.31M | 3.43M | 2.45M | 688.00K | 100.00K |
| Foreign Exchange rate Adjustments | 0.00 | 6.00K | 4.00K | 17.00K | 7.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.40M | -18.45M | -10.10M | -16.88M | -27.13M |
